ACIP recommends PCV13 for all adults 65 and up

All adults who are 65 years or older should receive 13-valent pneumococcal conjugate vaccine (PCV13) routinely in series with 23-valent pneumococcal polysaccharide vaccine (PPSV23), according to a...

Field of Interest: Geriatrics
Type: News Item

No blood clot risk found with HPV vaccination

The quadrivalent human papillomavirus vaccine does not increase the risk of venous thromboembolism, a study showed. Two previous studies finding an association, one based on the Vaccine Adverse...

Field of Interest: Pulmonology
Type: News Item

Women benefit from CRT at shorter QRS durations

Women with mild heart failure and left bundle branch block benefit from cardiac resynchronization therapy at a shorter QRS duration – less than 150 milliseconds – than do men, according to a report...

Field of Interest: Pulmonology
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.